Cargando…

Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection

BACKGROUND: Lingering post-treatment parasite antigen in blood complicates malaria diagnosis through antigen detection. Characterization of antigen clearance dynamics is important for interpretation of positive antigen detection tests. RESULTS: We used a bead-based serological assay to measure lacta...

Descripción completa

Detalles Bibliográficos
Autores principales: Plucinski, Mateusz M., McElroy, Peter D., Dimbu, Pedro Rafael, Fortes, Filomeno, Nace, Doug, Halsey, Eric S., Rogier, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558726/
https://www.ncbi.nlm.nih.gov/pubmed/31182154
http://dx.doi.org/10.1186/s13071-019-3549-x
_version_ 1783425685844393984
author Plucinski, Mateusz M.
McElroy, Peter D.
Dimbu, Pedro Rafael
Fortes, Filomeno
Nace, Doug
Halsey, Eric S.
Rogier, Eric
author_facet Plucinski, Mateusz M.
McElroy, Peter D.
Dimbu, Pedro Rafael
Fortes, Filomeno
Nace, Doug
Halsey, Eric S.
Rogier, Eric
author_sort Plucinski, Mateusz M.
collection PubMed
description BACKGROUND: Lingering post-treatment parasite antigen in blood complicates malaria diagnosis through antigen detection. Characterization of antigen clearance dynamics is important for interpretation of positive antigen detection tests. RESULTS: We used a bead-based serological assay to measure lactate dehydrogenase (LDH), aldolase (Aldo), and histidine-rich protein 2 (HRP2) levels in 196 children with Plasmodium falciparum malaria treated with effective antimalarials and followed for 28 to 42 days as part of therapeutic efficacy studies in Angola. Compared to pre-treatment levels, antigen concentrations two days after treatment declined by 99.7% for LDH, 96.3% for Aldo, and 54.6% for HRP2. After Day 2, assuming a first-order kinetics clearance model, half-lives of the antigens were 1.8 days (95% CI: 1.5–2.3) for LDH, 3.2 days (95% CI: 3.0–3.4) for Aldo, and 4.8 days (95% CI: 4.7–4.9) for HRP2. CONCLUSIONS: LDH and Aldo show substantially different clearance rates than HRP2, and their presence is largely indicative of active infection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13071-019-3549-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6558726
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65587262019-06-13 Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection Plucinski, Mateusz M. McElroy, Peter D. Dimbu, Pedro Rafael Fortes, Filomeno Nace, Doug Halsey, Eric S. Rogier, Eric Parasit Vectors Research BACKGROUND: Lingering post-treatment parasite antigen in blood complicates malaria diagnosis through antigen detection. Characterization of antigen clearance dynamics is important for interpretation of positive antigen detection tests. RESULTS: We used a bead-based serological assay to measure lactate dehydrogenase (LDH), aldolase (Aldo), and histidine-rich protein 2 (HRP2) levels in 196 children with Plasmodium falciparum malaria treated with effective antimalarials and followed for 28 to 42 days as part of therapeutic efficacy studies in Angola. Compared to pre-treatment levels, antigen concentrations two days after treatment declined by 99.7% for LDH, 96.3% for Aldo, and 54.6% for HRP2. After Day 2, assuming a first-order kinetics clearance model, half-lives of the antigens were 1.8 days (95% CI: 1.5–2.3) for LDH, 3.2 days (95% CI: 3.0–3.4) for Aldo, and 4.8 days (95% CI: 4.7–4.9) for HRP2. CONCLUSIONS: LDH and Aldo show substantially different clearance rates than HRP2, and their presence is largely indicative of active infection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13071-019-3549-x) contains supplementary material, which is available to authorized users. BioMed Central 2019-06-10 /pmc/articles/PMC6558726/ /pubmed/31182154 http://dx.doi.org/10.1186/s13071-019-3549-x Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Plucinski, Mateusz M.
McElroy, Peter D.
Dimbu, Pedro Rafael
Fortes, Filomeno
Nace, Doug
Halsey, Eric S.
Rogier, Eric
Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection
title Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection
title_full Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection
title_fullStr Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection
title_full_unstemmed Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection
title_short Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection
title_sort clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for plasmodium falciparum infection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558726/
https://www.ncbi.nlm.nih.gov/pubmed/31182154
http://dx.doi.org/10.1186/s13071-019-3549-x
work_keys_str_mv AT plucinskimateuszm clearancedynamicsoflactatedehydrogenaseandaldolasefollowingantimalarialtreatmentforplasmodiumfalciparuminfection
AT mcelroypeterd clearancedynamicsoflactatedehydrogenaseandaldolasefollowingantimalarialtreatmentforplasmodiumfalciparuminfection
AT dimbupedrorafael clearancedynamicsoflactatedehydrogenaseandaldolasefollowingantimalarialtreatmentforplasmodiumfalciparuminfection
AT fortesfilomeno clearancedynamicsoflactatedehydrogenaseandaldolasefollowingantimalarialtreatmentforplasmodiumfalciparuminfection
AT nacedoug clearancedynamicsoflactatedehydrogenaseandaldolasefollowingantimalarialtreatmentforplasmodiumfalciparuminfection
AT halseyerics clearancedynamicsoflactatedehydrogenaseandaldolasefollowingantimalarialtreatmentforplasmodiumfalciparuminfection
AT rogiereric clearancedynamicsoflactatedehydrogenaseandaldolasefollowingantimalarialtreatmentforplasmodiumfalciparuminfection